Best Renal Artery Stenosis Treatment Doctors in India
Whatsapp Us
Dr. Puneet Jandial
Dr. Jeewan Pillai
Dr. Preethi Sharma
Dr Anand Deodhar
Dr. Fayaz Uddin
Dr. Ashutosh Kumar Pandey
Dr. Junish Singh Bagga
Dr. Ashish N Badkhal
Dr. Robert Mao
What Patients with Renal Artery Stenosis Worry About Most
Renal artery stenosis is narrowing of the artery supplying a kidney, usually due to atherosclerosis (older patients) or fibromuscular dysplasia (younger women). Patients worry that the kidney will be lost, that uncontrolled high blood pressure will lead to stroke or heart attack, and that stenting may not actually help. Many are picked up after resistant hypertension or after a sudden rise in serum creatinine on starting an angiotensin-converting enzyme inhibitor. The honest position is that not every renal artery stenosis needs stenting; the decision depends on the cause, the severity, and the response to medical therapy.
How Renal Artery Stenosis Is Diagnosed
Diagnosis combines clinical clues with imaging. Suspicion is raised by resistant hypertension (uncontrolled on three drugs including a diuretic), unexplained acute kidney injury after starting an angiotensin-converting enzyme inhibitor or angiotensin receptor blocker, asymmetric kidney size, recurrent flash pulmonary oedema, or a renal bruit on examination. Duplex ultrasound is the first test, measuring peak systolic velocity and renal-aortic ratio. Computed tomography angiography and magnetic resonance angiography confirm stenosis and map anatomy. Digital subtraction angiography with pressure measurement is used when intervention is planned, particularly in fibromuscular dysplasia.
Treatment Options for Renal Artery Stenosis in India
Treatment is individualised. Atherosclerotic renal artery stenosis is treated mainly with best medical therapy: angiotensin-converting enzyme inhibitor or angiotensin receptor blocker (with careful monitoring of creatinine), other antihypertensives as needed, statin, antiplatelet, and risk factor control. The CORAL trial showed no additional benefit from routine renal artery stenting over medical therapy alone in most patients. Stenting is reserved for resistant hypertension despite maximum medical therapy, declining kidney function attributable to renal artery stenosis, or recurrent flash pulmonary oedema. Fibromuscular dysplasia responds well to balloon angioplasty without stenting in most cases, with hypertension cure rates above thirty to fifty percent. Surgical revascularisation (aortorenal bypass, splanchnorenal bypass) is reserved for complex anatomy or stent failure. Fortis Escorts Heart Institute, Medanta, Apollo Hospitals, Narayana Hrudayalaya, and All India Institute of Medical Sciences run dedicated renal vascular programmes.
Recovery, Success Rates, and Follow-Up After Renal Intervention
Balloon angioplasty for fibromuscular dysplasia has technical success above ninety percent and improves or cures hypertension in fifty to seventy percent. Atherosclerotic renal artery stenting has technical success above ninety-five percent but only modest blood pressure improvement on average. Restenosis rates are five to fifteen percent over two years. Follow-up duplex ultrasound is done at three months, six months, then yearly, with blood pressure monitoring and creatinine. Best medical therapy continues lifelong.
How to Choose the Right Specialist for Renal Artery Stenosis
Ask whether the centre has both interventional cardiology or radiology and nephrology input, since renal artery stenosis sits at the boundary. Confirm that the indication for stenting is reviewed against current guidelines (most atherosclerotic cases should not be stented routinely). Ask about volumes of renal artery angioplasty and stenting per year. Centres that follow European Society of Cardiology and Society for Cardiovascular Angiography and Interventions criteria are usually the better choice.
Support for International Patients
Renal artery angioplasty and stenting in India cost a fraction of comparable care in the United Kingdom, the United States, or the United Arab Emirates. Cancer Rounds arranges medical visa invitation letters, accommodation near the vascular centre, multilingual support in eleven plus languages, and remote duplex and creatinine follow-up after return home. We have supported patients from Nigeria, Kenya, Bangladesh, Iraq, Ethiopia, and Oman through both fibromuscular dysplasia angioplasty and atherosclerotic renal stenting in India.
Frequently Asked Questions
Do I need stenting just because I have renal artery stenosis?
No. The CORAL trial showed that most atherosclerotic renal artery stenosis cases do as well with best medical therapy alone. Stenting is reserved for resistant hypertension, declining kidney function attributable to stenosis, or flash pulmonary oedema.
What is fibromuscular dysplasia?
Fibromuscular dysplasia is a non-atherosclerotic, non-inflammatory disease causing string-of-beads appearance in the renal arteries, typically in young to middle-aged women. It responds well to balloon angioplasty without stenting.
Will I be able to stop blood pressure drugs after stenting?
Fibromuscular dysplasia angioplasty cures or markedly improves hypertension in fifty to seventy percent. Atherosclerotic stenting rarely allows complete drug withdrawal because hypertension usually has multiple causes.
Can angiotensin-converting enzyme inhibitors be used in renal artery stenosis?
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers are first-line antihypertensives in most renal artery stenosis cases. Creatinine is monitored carefully; a rise of less than thirty percent is acceptable.
How is renal artery stenosis different from kidney failure?
Renal artery stenosis is narrowing of the artery supplying a structurally intact kidney. Kidney failure refers to loss of kidney function from any cause. Stenosis is one of many possible causes of kidney injury.
Will I need lifelong follow-up after stenting?
Yes. Duplex ultrasound, blood pressure, and creatinine are checked at three months, six months, then yearly. Lifelong antiplatelet and statin therapy continues for atherosclerotic disease.
